Fulcrum Therapeutics merges with Slate Medicines…ticker SLTE
FULC Fulcrum Therapeutics Inc
$3.86 +3.21%
View chart & analysis → - 1Fulcrum Therapeutics (FULC) merges with Slate Medicines…surviving company Slate, Nasdaq: SLTE
- 2Slate oversubscribed in $245M+ private placement led by Frazier and others…secures operating funds through 2029
- 3Targets next-generation treatments for migraine and headache…proceeds to fund clinical milestones for pipeline including SLTE-1009
This 3-line summary is compiled from the report below.
Exec Edge +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다